Hub-Based Engagement Navigator Service to Reduce CSC Disengagement
ConditionDisengagement
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age13-35
SponsorUniversity of Maryland, Baltimore
About this trial
This project will develop a hub-based engagement navigator service for participants and families at high risk for disengagement. The investigators will use robust Participatory Research methods to ensure integration of Coordinated Specialty Care (CSC) program staff, participants, and family members in developing all aspects of and materials for the service, conduct feasibility/acceptability testing in three CSC programs, and use this information to guide refinements. This will be followed by a mixed methods hub wide evaluation using a hybrid type I open cohort stepped wedge design to examine feasibility, acceptability, and effectiveness to improve disengagement outcomes and address target mechanisms.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients receiving services at Coordinated Specialty Care programs for the treatment of early episode psychosis
Age 13-35
Disqualifiers
Do not meet inclusion criteria
Trial design
Design model
Sequential
Treatments tested in this trial
Engagement Navigator Service (ENS)
Other interventionENS will be a centralized service, staffed by dedicated professional to (1) receive and organize referrals, (2) complete ongoing specialized training in engagement science and evidence-based strategies, (3) provide unbiased support when participants' and/or families' relationships with a CSC program are poor, (4) re-engage participants in CSC or actively connect them with other services if preferred, and (5) continue contact with those who refuse treatment in case they reconsider.
Treatment groups
555 Participants
are divided into 2 treatment groupsGroup A: Engagement Navigator Service (ENS)Experimental treatment 1 intervention
Group B: No ENSNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Rate of discharge
The investigators will compare rate of disengagement for CSC participants with ENS access to those in usual care who do not have ENS access.
Time frame
From enrollment to end of treatment at 2 years2
Time in treatment
The investigators will compare time in treatment for participants with ENS access to that of participants in usual care who do not have ENS access.
Time frame
From enrollment to end of treatment at 2 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov